Charles Bahn, MD, Remarks on Link Between Eye Exams and Stroke Prevention
Online, July 2, 2012 (Newswire.com) - New and recurrent strokes are serious medical emergencies that affect nearly 800,000 Americans every year. Doctors have linked carotid artery stenosis (CAD), a condition that blocks essential arteries and prevents blood from reaching the brain, to a higher risk of stroke. Unfortunately for those who suffer from CAD, this condition is one that proves difficult to detect, as frequently there are no symptoms prior to stroke. However, one recent article from The Wall Street Journal indicates that a new and simple procedure performed during a routine eye exam may help to determine whether or not a patient is at risk of stroke due to CAD. Charles Bahn, MD is an ophthalmologist in the Maryland area and is excited by these developments and is encouraged by the preventative impact the procedure can have.
A new study published by the American Academy of Ophthalmology observes that this test, known as ocular pulse amplitude (OPA), demonstrates a link between eye function and CAD. Participants in the study who had low OPA scores also displayed high rates or artery blockage. According to the article, this is unique because lower OPA scores have no direct connection to any other major illness or condition. A Swiss research team utilized an ophthalmologic device known as a dynamic contour tonometer to measure these scores.
Dr. Bahn notes that the study is particularly interesting because it lends greater insight into the holistic operation of the body. As an observer of current medical trends, Charles Bahn, MD comments, "The opportunity to diagnosis carotid artery blockages, before they cause strokes, is an important healthcare advance. The development of tests such as measurement of the ocular pulse amplitude ("OPA") to detect and prevent disease is at the forefront of modern medicine."
Dr. Bahn continues by stating that these tests demonstrate their true worth if they can be conducted during routine scheduled appointments, such as annual eye checkups. The article notes, "It could be efficient to perform the OPA test during a standard eye exam, if the ophthalmologist is already using the dynamic contour tonometer to screen for glaucoma." Dr. Bahn also adds that a test that does not involve pain is great because patients are more willing to try it. However, the dynamic contour tonometer is not widely used in the US as of yet, prompting eye doctors and medical professionals such as Charles Bahn, MD , to encourage wider use of the technology.
ABOUT:
Charles Bahn, MD is a practicing ophthalmologist serving patients in Bethesda, Maryland. In addition to glaucoma detection and treatment, Dr. Bahn specializes in corneal and external eye diseases. He earned his medical degree, master's degrees and bachelor's degrees from Tulane University as well as the University of Michigan at Ann Arbor. He continues to use this extensive professional and educational background to treat patients at his private practice.